Fiscal Year 2024 Oversight Plan for the Department of Defense Office of Inspector General

The plan describes the DoD OIG’s ongoing and planned oversight in support of key focus areas and the DoD OIG’s FY 2024 assessment of the Top DoD Management and Performance Challenges.

Fiscal Year 2024 Oversight Plan for the Department of Defense Office of Inspector General

Report of Investigation: Mr. William K. Lietzau (DODIG-2024-040)

Inspector General Robert P. Storch announced today that the Department of Defense Office of Inspector General released the “Report of Investigation: Mr. William K. Lietzau, Former Director, Defense Counterintelligence and Security Agency.

Report of Investigation: Mr. William K. Lietzau (DODIG-2024-040)

Quality Control Review of the PricewaterhouseCoopers LLP (DODIG-2024-039)



Quality Control Review of the PricewaterhouseCoopers LLP (DODIG-2024-039)

Opioid Prescription Compliance with Federal and DoD Opioid Safety Standards (DODIG-2024-036)

Defense Health Agency (DHA) had controls in place to monitor opioid prescriptions and ensure compliance with Federal and DoD opioid safety recommendations and requirements.

Opioid Prescription Compliance with Federal and DoD Opioid Safety Standards (DODIG-2024-036)

Common Cybersecurity Weaknesses Related to the Protection of DoD CUI (DODIG-2024-031)

This special report provides insight into the common cybersecurity weaknesses identified in DoD Office of Inspector General audit.

Common Cybersecurity Weaknesses Related to the Protection of DoD CUI (DODIG-2024-031)

Diversity and Inclusion and Extremism in the Military Report

This annual report addresses the reporting requirements pursuant to section 554 of the FY 2021 National Defense Authorization Act (NDAA).

Diversity and Inclusion and Extremism in the Military Report

Click for Hotline Homepage

Press Release: Fiscal Year 2024 Oversight Plan for the Department of Defense Office of Inspector General
Dec. 20, 2023
Inspector General Robert P. Storch announced today that the Department of Defense Office of Inspector General released its “Fiscal Year 2024 Oversight Plan.”
Press Release: Report of Investigation: Mr. William K. Lietzau, Former Director, Defense Counterintelligence and Security Agency, Office of the Under Secretary of Defense for Intelligence and Security (DODIG-2024-040)
Dec. 18, 2023
Inspector General Robert P. Storch announced today that the Department of Defense Office of Inspector General released the “Report of Investigation: Mr. William K. Lietzau, Former Director, Defense Counterintelligence and Security Agency, Office of the Under Secretary of Defense for Intelligence and Security.”
Press Release: Audit of Defense Health Agency Controls to Monitor Opioid Prescription Compliance with Federal and DoD Opioid Safety Standards (DODIG-2024-036)
Dec. 7, 2023
Inspector General Robert P. Storch announced today that the Department of Defense Office of Inspector General released the “Audit of Defense Health Agency Controls to Monitor Opioid Prescription Compliance with Federal and DoD Opioid Safety Standards.
Read More
Report of Investigation: Mr. William K. Lietzau former Director, Defense Counterintelligence and Security Agency (DODIG-2024-040)
Dec. 18, 2023
Inspector General Robert P. Storch announced today that the Department of Defense Office of Inspector General released the “Report of Investigation: Mr. William K. Lietzau, Former Director, Defense Counterintelligence and Security Agency, Office of the Under Secretary of Defense for Intelligence and Security".
Quality Control Review of the PricewaterhouseCoopers LLP and Defense Contract Audit Agency FY 2022 Single Audit of the Charles Stark Draper Laboratory, Inc. (DODIG-2024-039)
Dec. 18, 2023
The objective of this quality control review was to determine whether PricewaterhouseCoopers LLP and the Defense Contract Audit Agency performed the FY 2022 single audit of the Charles Stark Draper Laboratory, Inc. in accordance with generally accepted government auditing standards and Federal requirements for single audits.
Project Announcement: Evaluation of Accountability Controls for Seaports of Debarkation in the U.S. European Command Area of Responsibility (D2024-DEV0PD-0030.000)
Dec. 18, 2023
The objective of this evaluation is to determine whether the U.S. European Command is effectively scaling, stocking, staffing, and preparing select seaports for movement of equipment provided to foreign partners. We may revise the objective as the evaluation proceeds, and we will also consider suggestions from management for additional or revised objectives.
Read More
Phillips Respironics Pays $2.4 Million for Allegedly Giving Kickbacks
Dec. 22, 2023
Phillips Respironics, a manufacturer of durable medical equipment based in Pennsylvania, has paid $2,471,359.25 to resolve allegations that it violated the False Claims Act by giving kickbacks to sleep laboratories. The Anti-Kickback Statute prohibits paying money or giving goods to induce referrals for medical services or items covered by a federal health care program, such as Medicare, Medicaid or TRICARE. Claims submitted to these programs in violation of the Anti-Kickback Statute give rise to liability under the False Claims Act.
Owner of Marketing Companies Admits Role in $24 Million Health Care Fraud and Kickback Scheme
Dec. 21, 2023
An Ohio man and owner of several marketing companies today admitted his role in conspiracies to commit health care fraud and to pay and receive illegal kickbacks, Attorney for the United States Vikas Khanna announced.
United States Reaches $9.1 Million Civil Settlement with Total Access Urgent Care Over False Claims Allegations
Dec. 21, 2023
The U.S. Attorney’s Office for the Eastern District of Missouri announced today that Total Access Urgent Care (TAUC) has agreed to pay $9,150,794 to settle allegations that TAUC submitted false claims for medical services, including COVID-19 testing.

Read More